Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep723 | Pituitary and Neuroendocrinology | ECE2020

Soluble alpha klotho measurement: Comparison of measurements by different commercially available assays in healthy subjects and active acromegaly

Ribeiro de Oliveira Longo Schweizer Junia , Schilbach Katharina , Haenelt Michael , Störmann Sylvère , Schopohl Jochen , Bidlingmaier Martin

Background: Recent studies reported high soluble α-klotho concentrations (α-klotho) in active acromegaly, with normalization after successful therapy. We showed that α-klotho correlates to GH and even better to IGF-I. So far, most studies employed an immunoassay from Immuno-Biological Laboratories (IBL) for measurement of α-klotho, but other assays are available. Agreement between assays remains questionable since α-klotho exists in several isoforms: K...

ea0032p1101 | Thyroid cancer | ECE2013

Thyroglobulin levels in the washout of lymph node fine-needle aspirate on patients with previous history of differentiated thyroid cancer

Gouveia Sofia , Ribeiro Cristina , Paiva Sandra , Alves Marcia , Saraiva Joana , Moreno Carolina , Guelho Daniela , Leitao Fatima , Carrilho Francisco

Introduction: Our aim was to determine the comparable value of thyroglobulin in the washout of lymph node fine-needle aspirate (FNATg) and fine-needle aspiration biopsy (FNAB).Materials and methods: We included 29 patients (37 FNAB) with history of differentiated thyroid cancer who underwent total thyroidectomy and were found to have suspicious cervical lymph nodes during follow-up. The referred population was evaluated on what concerns to gender, age, s...

ea0029p407 | Clinical case reports - Thyroid/Others | ICEECE2012

Considering familial benign hypocalciuric hypercalcemia on differential diagnosis of primary hyperparathyroidism

Gouveia S. , Paiva S. , Gomes L. , Ribeiro C. , Vieira A. , Alves M. , Saraiva J. , Moreno C. , Carvalheiro M.

Introduction: Primary hyperparathyroidism is the most common cause for hypercalcemia. Familial benign hypocalciuric hypercalcemia (FBHH) is an unusual autosomal dominant disease. The mutation in the calcium sensing receptor (CaSR) determines a shift to the right in the calcemia set-point that inhibits PTH secretion. Generally asymptomatic, these patients present with mild hypercalcemia and hypophosphatemia, normal or slightly increased PTH levels and hypocalciuria. Daily calci...

ea0026p229 | Pituitary | ECE2011

Clinical and subclinical apoplexy in nonfunctioning pituitary tumors: clinical features, management and outcome

Gomes Leonor , Paiva Isabel , Ribeiro Cristina , Santos Jacinta , Vieira Alexandra , Alves Marcia , Gouveia Sofia , Saraiva Joana , Rebelo Olinda , Carvalheiro Manuela

Background: Pituitary apoplexy occurs when a tumor undergoes acute hemorrhage, infarct, or both. This often leads to acute severe symptoms (clinical) but can also occur without them and diagnosed on CT/MRI, surgery, pathology (subclinical). To investigate clinical and subclinical apoplexy in nonfunctioning tumors (n=221) from our database.Design: Retrospective review of clinical presentation, tumor characteristics and outcome of 24 patients, 11 fe...

ea0022p185 | Clinical case reports and clinical practice | ECE2010

Primary biliary cirrhosis and Graves’ disease – combination rarely found

Vieira Alexandra , Paiva Sandra , Ribeiro Cristina , Santos Jacinta , Martinho Mariana , Alves Marcia , Gouveia Sofia , Carrilho Francisco , Carvalheiro Manuela

Introduction: The association of autoimmune diseases in the same individual is common. It is well documented that Graves’ disease (GD) is associated to various autoimmune diseases, including: pernicious anemia, vitiligo, type 1 diabetes, Addison’s disease, systemic sclerosis, myasthenia gravis, Sjogren’s syndrome, rheumatoid arthritis and systemic lupus erythematosus. In addition, primary biliary cirrhosis (PBC) may be associated with rheumatoid arthritis, Sjogr...

ea0022p413 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Von Hippel-Lindau disease: a case report

Gouveia Sofia , Ribeiro Cristina , Paiva Sandra , Joao Bugalho Maria , Santos Jacinta , Vieira Alexandra , Alves Marcia , Carvalheiro Manuela

Introduction: Von Hippel-Lindau disease (VHLD) is a rare autosomal-dominant syndrome, characterized by the development of multiple cysts and tumours, namely retinal and central nervous system hemangioblastomas, renal cell carcinoma (RCC), phaeochromocytoma, pancreatic endocrine tumours (PET) and endolymphatic sac tumours.Most germinal mutations are missense, related to a high risk for presenting phaechromocytoma (specially if Arg167Trp mutation im...

ea0022p804 | Thyroid | ECE2010

Ultrasound fine needle aspiration (US – FNA) in an Endocrinology Department: our reality and results quality

Ribeiro Cristina , Paiva Sandra , Gouveia Sofia , Fernandes Graca , Melo Miguel , Santos Jacinta , Vieira Alexandra , Alves Marcia , Carrilho Francisco , Carvalheiro Manuela

Introduction: High-resolution US and US FNA are techniques of great relevance in the evaluation of thyroid nodules. They are being used much more often by endocrinologists all over the world. In our Endocrinology Department, we started them in 2006; since then they have been progressively amplified. We present our results of US FNA performed from January 2007 until December 2009.Patients and methods: Two thousand eight hundred and seventy-seven FNA were ...

ea0014p143 | (1) | ECE2007

Somatostatin analogues and the PI3K-AKT-MTOR-P70S6K pathway: how do they control the proliferation of neuroendocrine tumours?

Franchi Giulia , Grozinsky-Glasberg Simona , de Oliveira Antonio Ribeiro , Salahuddin Nabila , Korbonits Márta , Grossman Ashley B.

Background: Somatostatin analogues are very useful in the treatment of symptomatic neuroendocrine tumours, but effects on proliferation remain unclear. Overexpression of the proto-oncogene protein kinase Akt has been demonstrated in certain endocrine tumours, and activates downstream proteins including mTOR and p70S6K, which play a significant role in cell growth and proliferation. We have therefore explored the site of action of somatostatin in causing inhibition of prolifera...

ea0056ep68 | Diabetes, Obesity and Metabolism | ECE2018

Diabetic ketoacidosis and dapagliflozin: a case report

Catarino Diana , Ribeiro Cristina , Oliveira Diana , Martins Diana , Lages Adriana , Ventura Mara , Cunha Nelson , Fadiga Lucia , Marques Bernardo , Carrilho Francisco

Introduction: Dapagliflozin is an oral antidiabetic drug, recently approved for type 2 diabetes and is a sodium-glucose cotransporter type 2 inhibitor (iSGLT2). Its mechanism of action is glycosuria induction, associated with lowering glycemia. The effects of SGLT2 inhibition are insulin-independent, and efficacy is not affected by declining β-cell function or insulin resistance. Additional benefits: weight loss, reduction in blood pressure, lower inciden...

ea0093oc11 | Oral communication 2: Neuroendocrinology | EYES2023

Soluble alpha klotho, a new biomarker of growth hormone action

Schweizer Junia Ribeiro de Oliveira Longo , Schilbach Katharina , Gagliardo Anica Pauline , Haenelt Michael , Peters Annette , Thorand Barbara , Bidlingmaier Martin

Background: Soluble alpha klotho (sαKL) is high in active acromegaly, normalizes after disease control, and therefore is suggested as a new biomarker for growth hormone (GH) excess. However, little is known about the impact of biological variables other than GH.Methods: Serum sαKL (pg/ml) was measured by ELISA (IBL, Hamburg, Germany). We first evaluated pre-analytical stability, defined a reference interval for sαKL in healthy subjects (A:...